Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of reduction therapy of natural human β-interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 2 and high virus load.
Arase Y, Suzuki Y, Suzuki F, Akuta N, Sezaki H, Kawamura Y, Kobayashi M, Imai N, Seko Y, Hosaka T, Matsumoto N, Saito S, Ikeda K, Kobayashi M, Kumada H. Arase Y, et al. Among authors: seko y. Hepatol Res. 2012 Aug;42(8):750-6. doi: 10.1111/j.1872-034X.2012.00982.x. Epub 2012 Mar 26. Hepatol Res. 2012. PMID: 22776551
Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients.
Suzuki F, Suzuki Y, Sezaki H, Akuta N, Seko Y, Kawamura Y, Hosaka T, Kobayashi M, Saito S, Arase Y, Ikeda K, Mineta R, Watahiki S, Kobayashi M, Nakayasu Y, Tsuda H, Aoki K, Yamada I, Kumada H. Suzuki F, et al. Among authors: seko y. Hepatol Res. 2013 Jul;43(7):691-701. doi: 10.1111/hepr.12009. Epub 2012 Nov 29. Hepatol Res. 2013. PMID: 23190247
Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease.
Arase Y, Kawamura Y, Seko Y, Kobayashi M, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Ohmoto-Sekine Y, Hsieh SD, Amakawa K, Ogawa K, Matsumoto N, Iwao A, Tsuji H, Hara S, Mori Y, Okubo M, Sone H, Kobayashi T. Arase Y, et al. Among authors: seko y. Hepatol Res. 2013 Nov;43(11):1163-8. doi: 10.1111/hepr.12077. Epub 2013 Mar 12. Hepatol Res. 2013. PMID: 23489256
Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K, Nishimura T, Ishiba H, Seko Y, Okajima A, Fujii H, Tochiki N, Umemura A, Moriguchi M, Sumida Y, Mitsuyoshi H, Yasui K, Minami M, Okanoue T, Itoh Y. Yamaguchi K, et al. Among authors: seko y. Liver Int. 2015 Feb;35(2):550-61. doi: 10.1111/liv.12645. Epub 2014 Aug 12. Liver Int. 2015. PMID: 25066281
Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease.
Sumida Y, Yonei Y, Tanaka S, Mori K, Kanemasa K, Imai S, Taketani H, Hara T, Seko Y, Ishiba H, Okajima A, Yamaguchi K, Moriguchi M, Mitsuyoshi H, Yasui K, Minami M, Itoh Y. Sumida Y, et al. Among authors: seko y. Hepatol Res. 2015 Jul;45(7):771-81. doi: 10.1111/hepr.12408. Epub 2014 Sep 30. Hepatol Res. 2015. PMID: 25163357
360 results